2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow abelacimab: new trials by email Literature Review of abelacimab trials Research Report on abelacimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Abelacimab, Dalteparin - Venous Thromboembolism, Deep Venous Thrombosis | Phase 3 | Terminated | Anthos Therapeutics, Inc. | 417 | 2022-09-27 | 2026-04-17 |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE Abelacimab, Apixaban - Venous Thromboembolism, Deep Venous Thrombosis | Phase 3 | Terminated | Anthos Therapeutics, Inc. | 1150 | 2022-05-05 | 2026-02-23 |
Pulmonary Embolism (2) · Venous Thromboembolism (2) · Venous Thrombosis (2) · Gastrointestinal Neoplasms (1)
Australia (2) · Austria (2) · Canada (2) · China (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Ireland (2) · Italy (2) · Latvia (2) · Netherlands (2) · Norway (2) · South Korea (2) · Spain (2)
2023 (1)